Fitting the Right Disease Modifying Therapy to the Patient with Multiple Sclerosis

Fitting the Right Disease Modifying Therapy to the Patient with Multiple Sclerosis is organized by College of Psychiatric and Neurologic Pharmacists (CPNP). This Course has been approved for a maximum of 1.0 Contact Hours.

Activity Dates: 06/01/2018 - 04/24/2021

Target Audience:
This course is designed for pharmacists and/or other healthcare professionals involved in the medication management of individuals living with psychiatric, neurologic and/or substance use disorders.

Session Summary:
Several new agents for multiple sclerosis have been approved in recent years, including the first medicine to be approved for progressive forms of the disease. With many new choices, it is difficult for the clinician to determine the preferred treatment for an individual patient. Some guidelines, consensus statements, algorithms, and patient preference studies exist for determining the most appropriate treatment choice for an individual, but they are not widely known and often ignored. Additionally, the pace of new medication approval has rendered many of these publications obsolete. There is evidence that patients have difficulty understanding the risks and benefits of medications to treat multiple sclerosis. This program will review the newly approved agents and discuss their place in therapy. Determining the appropriate therapy for specific patients will be emphasized. Additionally, methods for assisting patients in understanding the risks and benefits of the therapies for multiple sclerosis will be explained.

Course Requirements:
You will proceed through the following steps to satisfactorily complete this course:
• Review the full content of the activity and reflect upon its teachings.
• Complete the post-test at the end of the activity no later than the closing activity date. (login first)
• Complete the evaluation at the end of the activity. (login first)
• If necessary, complete the post-test retest no later than the closing activity date. (login first)
• Receive a passing grade (70%).
• Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

Learning Objectives
• List risks and benefits of newly approved medications for multiple sclerosis.
• Choose appropriate therapy for multiple sclerosis patients, considering patient-specific factors.
• Assist patients in understanding the risks and benefits of particular multiple sclerosis therapies.